Articular Cartilage Defect clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • NOVOCART®3D for Treatment of Articular Cartilage of the Knee

    open to eligible people ages 18-65

    This study is to compare NOVOCART 3D relative to Microfracture for the treatment of knee cartilage defects. Efficacy will be evaluated by both pain and function. Safety will also be evaluated.

    Los Angeles, California and other locations

Our lead scientists for Articular Cartilage Defect research studies include .

Last updated: